Severe Injury & Surgery Recovery (Subcutaneous or Intramuscular Injection) Dose: 500-1000 mcg twice daily Duration: 4-8 weeks Method: Subcutaneous (SubQ): Near the injury Intramuscular (IM): Directly into the muscle if applicable Best for: Post-surgical healing, chronic tendonitis, major muscle damage 4
The science is biologically plausible, the early findings are encouraging, and the available safety data appears favorable, but its important to be transparent about what we know, what we dont know, and where the evidence still needs to mature
Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."
Use our Genetic Risk Assessment Tool to understand your personal baseline skin cancer risk
Minerva Endocrinol (2021) 46:16876